المؤلفون: Kristensen, Soren L., Preiss, David, Jhund, Pardeep S., Squire, Iain, Cardoso, Jose Silva, Merkely, Bela, Martinez, Felipe, Starling, Randall C., Desai, Akshay S., Lefkowitz, Martin P., Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R., McMurray, John J. V., Packer, Milton

المساهمون: Neyses, Ludwig

المصدر: Circulation: Heart Failure, 9 (1) (2016)

مصطلحات موضوعية: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Biomarkers/blood, Blood Glucose/metabolism, Comorbidity, Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Disease-Free Survival, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Hemoglobin A, Glycosylated/metabolism, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prediabetic State/blood/diagnosis/epidemiology/mortality, Prevalence, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Single-Blind Method, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, Time Factors, Treatment Outcome

العلاقة: urn:issn:1941-3297; https://orbilu.uni.lu/handle/10993/29587Test; info:hdl:10993/29587; https://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest; scopus-id:2-s2.0-84955319328; info:pmid:26754626; wos:000368624200001

الإتاحة: https://doi.org/10.1161/CIRCHEARTFAILURE.115.002560Test
https://orbilu.uni.lu/handle/10993/29587Test
https://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest

المؤلفون: Aleksandr Svistov, YAN CARLOS DUARTE VERA, Lars Kober, Konstantin Ramshev, David Preiss, Miguel Urina, Sotir Marchev, Peter Olexa, Søren Lund Kristensen, Albert HAGEGE, Pardeep Jhund, Mamas Mamas, Ali Vazir, Michel GALINIER, Vladimir Rafalskiy, John Mcmurray, Angus Nightingale, Fernando Lanas, MICHELE SENNI, Jose Silva-Cardoso, Michael Zile, José Albuquerque De Figueiredo Neto, Elena Shutemova, Raj Mohindra, Natalie Bello, Gian Battista Danzi

المساهمون: Neyses, Ludwig [collaborator]

المصدر: Kristensen, S L, Preiss, D, Jhund, P S, Squire, I, Cardoso, J S, Merkely, B, Martinez, F, Starling, R C, Desai, A S, Lefkowitz, M P, Rizkala, A R, Rouleau, J L, Shi, V C, Solomon, S D, Swedberg, K, Zile, M R, McMurray, J J V, Packer, M & PARADIGM-HF Investigators and Committees 2016, ' Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction : Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial ', Circulation. Heart Failure, vol. 9, no. 1 . https://doi.org/10.1161/CIRCHEARTFAILURE.115.002560Test
Circulation. Heart Failure
Circulation. Heart failure, 9(1). United States (2016).

مصطلحات موضوعية: Blood Glucose, Male, Prediabetic State/blood, Time Factors, endocrine system diseases, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Left, heart failure, Tetrazoles, Aminobutyrates/adverse effects, Angiotensin-Converting Enzyme Inhibitors, Comorbidity, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Sacubitril, Ventricular Function, Left, Multidisciplinaire, généralités & autres [F99] [Sciences du vivant], 0302 clinical medicine, Enalapril, Risk Factors, Diabetes Mellitus/blood, Prevalence, Heart Failure/blood, Ventricular Function, Single-Blind Method, 030212 general & internal medicine, Prospective Studies, Enalapril/adverse effects/therapeutic use, Prediabetic State/blood/diagnosis/epidemiology/mortality, Ejection fraction, Aminobutyrates, Hazard ratio, clinical trial, Hemoglobin A, Angiotensin Receptor Antagonists/adverse effects, Middle Aged, Clinical trial, Drug Combinations, Treatment Outcome, Valsartan, Angiotensin-Converting Enzyme Inhibitors/adverse effects, diabetes mellitus, Cardiology, Female, Tetrazoles/adverse effects, Cardiology and Cardiovascular Medicine, medicine.drug, medicine.medical_specialty, prognosis, treatment outcome, Aged, Angiotensin Receptor Antagonists, Biomarkers, Diabetes Mellitus, Disease-Free Survival, Heart Failure, Hemoglobin A, Glycosylated, Humans, Prediabetic State, Proportional Hazards Models, Risk Assessment, Stroke Volume, Glycated Hemoglobin A/metabolism, Glycosylated, Multidisciplinary, general & others [F99] [Life sciences], Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Enalapril/adverse effects, Hemoglobin A, Glycosylated/metabolism, 03 medical and health sciences, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Diabetes mellitus, Internal medicine, medicine, Glycated Hemoglobin, Blood Glucose/metabolism, business.industry, Proportional hazards model, Biphenyl Compounds, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, nutritional and metabolic diseases, Aminobutyrates/adverse effects/therapeutic use, Original Articles, medicine.disease, Surgery, Tetrazoles/adverse effects/therapeutic use, Heart failure, business, Biomarkers/blood

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4175b6b03be4e6fe28284823591aa9dbTest
http://hdl.handle.net/11573/885449Test

مصطلحات الفهرس: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Biomarkers/blood, Blood Glucose/metabolism, Comorbidity, Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Disease-Free Survival, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Hemoglobin A, Glycosylated/metabolism, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prediabetic State/blood/diagnosis/epidemiology/mortality, Prevalence, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Single-Blind Method, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, Time Factors, Treatment Outcome, Ventricular Function, Left, clinical trial, diabetes mellitus, heart failure, prognosis, treatment outcome, info:eu-repo/semantics/article

URL: http://orbilu.uni.lu/handle/10993/29587Test
http://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest

مصطلحات الفهرس: Aged, Aminobutyrates/adverse effects/therapeutic use, Angiotensin Receptor Antagonists/adverse effects/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/adverse effects/therapeutic use, Biomarkers/blood, Blood Glucose/metabolism, Comorbidity, Diabetes Mellitus/blood/diagnosis/epidemiology/mortality, Disease-Free Survival, Drug Combinations, Enalapril/adverse effects/therapeutic use, Female, Heart Failure/blood/diagnosis/drug therapy/mortality/physiopathology, Hemoglobin A, Glycosylated/metabolism, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Prediabetic State/blood/diagnosis/epidemiology/mortality, Prevalence, Proportional Hazards Models, Prospective Studies, Risk Assessment, Risk Factors, Single-Blind Method, Stroke Volume, Tetrazoles/adverse effects/therapeutic use, Time Factors, Treatment Outcome, Ventricular Function, Left, clinical trial, diabetes mellitus, heart failure, prognosis, treatment outcome, info:eu-repo/semantics/article

URL: http://orbilu.uni.lu/handle/10993/29587Test
http://orbilu.uni.lu/bitstream/10993/29587/1/hhf-9-e002560.pdfTest